Participants 94 161 4
younger patients with nonacute promyelocytic acute myeloid leukemia
Participants 194 259 3
genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA
Participants 351 457 7
younger patients with nonacute promyelocytic acute myeloid leukemia and high-risk myelodysplastic syndrome
Participants 537 576 8
1075 patients less than 60 years of age
